SPO2 VALIDATION STUDY - PHILIPS FAST 2025
NCT: NCT07221526 · COMPLETED
NCT IDNCT07221526
StatusCOMPLETED
Start Date2025-10-28
Completion2026-02-05
Brief Summary
Clinical investigation is to validate the SpO2 accuracy of the M1133AX5, M1133AX6, and AlarX4 (nasal ala application) SpO2 sensors under test with the Philips FAST Pulse Oximetry technology.
Frequently Asked Questions
What is SPO2 VALIDATION STUDY - PHILIPS FAST 2025?
SPO2 VALIDATION STUDY - PHILIPS FAST 2025 is a clinical trial registered under NCT07221526. Current status: COMPLETED.
What is the status of NCT07221526?
The current status of NCT07221526 (SPO2 VALIDATION STUDY - PHILIPS FAST 2025) is: COMPLETED.
When did SPO2 VALIDATION STUDY - PHILIPS FAST 2025 start?
SPO2 VALIDATION STUDY - PHILIPS FAST 2025 started on 2025-10-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.